Skip to content
lifestyle.californiaconsumerbanking.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
OptimizeRx Corporation
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
June 25, 2026
Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis
June 2, 2026
OptimizeRx to Participate in Upcoming Investor Conferences
June 1, 2026
Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis
May 26, 2026
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network
May 21, 2026
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
May 12, 2026
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
May 11, 2026
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
May 8, 2026
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET
May 7, 2026
OptimizeRx Appoints Mary Varghese Presti to Board of Directors
May 5, 2026
1
2
Next Page
→